home / openregs / documents

documents: FDA-2013-D-1275-0014

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2013-D-1275-0014 FDA FDA-2013-D-1275 General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products Guidance for Industry; DRAFT GUIDANCE Other Guidance 2022-09-08T04:00:00Z 2022 9 2022-09-08T04:00:00Z 2022-12-08T04:59:59Z 2026-01-03T12:21:42Z   1 0 09000064852b7e96

Links from other tables

  • 0 rows from regs_document_id in fr_regs_crossref
Powered by Datasette · Queries took 0.458ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API